Objective: To determine the best regional pain score cutoff value that corresponds with patient-reported improvement in lumbosacral radiculopathy (LSR). Design: Retrospective pooled data analysis from 3 randomized, controlled, multicenter trials using similar outcome assessments. All participants were exposed to interventions (epidural injections). Setting: Military medical centers (6 U.S.A., 1 Germany) and large tertiary care hospitals (4 urban, 1 Veterans Affairs) between 2008 and 2014. Subjects: A total of 352 active duty military personnel and civilians ≥ 18 years of age with LSR. Methods: Receiver operating characteristics (ROC) with area under the curve (AUC) were calculated for 1-month outcomes for pain (numeric rating scale) using absolute and relative change in regional pain scores (back, leg) to predict clinical improvement (global perceived effect). .831]; P = 0.002) reduction in reported pain. Clinical improvement was best identified using a leg pain reduction threshold of ≥ 1.75 points (absolute) and ≥ 23.5% (relative). Conclusions: Region-specific pain cutoff ratings predicted clinical improvement for patients with LSR. Cutoff points using newly identified, smaller reductions of 1.75 points and 23.5% more accurately predicted clinical improvement for LSR than conventionally used cutoffs (2 points and 30%). LSR patients report meaningful clinical improvement with smaller reductions in pain compared to other chronic pain diagnoses, suggesting LSR patients may have different expectations. &
INTRODUCTION
Distinguishing between meaningful improvement and lack thereof in patient populations lies at the heart of effective clinical research. In the field of pain research, measurement of clinical characteristics and subsequent patient outcomes is complicated by the subjective nature of pain. 1 Consequently, approaches to assessing pain commonly employ numeric rating scales (NRS), visual analog scales (VAS), or other quantifiable instruments. 2 However, even with such quantitative data, it is challenging to determine what constitutes a meaningful change to patients. 3 Guidelines on the clinical importance of treatment outcomes in chronic pain studies indicate that a relative reduction of ≥ 30% represents a clinically meaningful difference for patients. 4 The most robust evidence for this benchmark originates from an analysis of 10 controlled studies of pregabalin in 2,724 patients. 5 Nonspecific chronic low back pain constituted the diagnosis among 2 studies of this cohort, which also included 4 other pain diagnoses: diabetic peripheral neuropathy, osteoarthritis, fibromyalgia, and postherpetic neuralgia. In this diverse collection of chronic pain conditions, an absolute reduction of 2 points on a 0-to 10-point scale or a relative reduction in 30% corresponded with a "clinically important difference" in patient response. 5 Other studies evaluating low back pain include a report by H€ agg et al., 6 which focused on 289 patients with nonspecific back pain without clinical or radiological evidence of nerve root compression. Using a 100-unit VAS, an 18-to 19-point reduction in pain corresponded with a meaningful improvement. 6 Finally, what constituted meaningful improvement for radicular pain was examined in a subgroup analysis performed in 75 patients who were randomized to receive either epidural steroid or saline injection as part of a clinical trial. The researchers found that a 30-point or 50% reduction in overall pain was the ideal cutoff to discriminate those who reported an important improvement in symptoms from those who described their improvement as poor. 7 Past investigations measured and analyzed changes in global pain scores, which characterize the total level of pain for a patient (elicited by questions such as "what is your overall level of pain?"). As clinical studies have evolved, more detailed pain scores specific to a body region or territory have been increasingly used (ie, "what is your level of back pain?"). Although some types of back pain may be nonspecific, lumbar radiculopathy is consistently characterized by pain in the lower back and one or both legs. 8 Clinical studies in these patients have begun to record pain scores specific to these 2 discrete regions of the body. However, regional pain scores may differ from global pain scores in their ability to denote clinically meaningful outcomes for patients given the former's greater capacity to capture more specific pain information. 9 Recently, 3 randomized clinical trials of patients with lumbar radiculopathy measured region-specific pain scores and meaningful improvement. [10] [11] [12] These studies recruited patients with lumbosacral radiculopathy (LSR) from both military and civilian hospitals. Patients underwent epidural injections, with most receiving steroid and some receiving sham, saline, or a cytokine inhibitor tumor necrosis factor (TNF)-a injection. All 3 studies masked assessment of outcome data, which included region-specific average pain scores over the preceding week for the back and legs. The aim of this study was to address the question of what change in pain score best corresponds with meaningful improvement in patients with chronic pain from lumbar radiculopathy. We hypothesized that reductions in leg pain would better predict a clinically meaningful response than reductions in back pain. Additionally, we posit that changes in pain scores for lumbar radiculopathy would be greater for leg compared to back pain.
METHODS

Study Design
We retrospectively examined de-identified data from a cohort of all participants enrolled in 3 randomized, controlled, multicenter chronic pain studies that utilized similar study procedures for the assessment of outcomes. [10] [11] [12] Prior to their conduction, all studies secured internal review board permission from every institution participating in patient recruitment, and all participants provided written informed consent. One study examined the impact of magnetic resonance imaging (MRI) on outcomes and decision making in patients referred for epidural steroid injection (ESI). After undergoing MRI, patients were randomized to physician MRI review or no review prior to ESI. MRI showed only a small effect on decision making and made no difference in outcomes. 11 The other 2 studies randomized patients to ESI or non-ESI treatments and favored ESI for modest, short-term pain relief in both cases. 10, 12 Comparison groups included a TNF-a inhibitor etanercept or saline in one 10 and gabapentin in the other. 12 Table 1 presents additional information about eligibility criteria for study participants.
Participants, Settings, and Interventions
Civilian and active duty military personnel ≥ 18 years of age with a diagnosis of LSR were recruited from pain clinics and primary care settings. Sites included 6 U.S. military medical centers as well as a military hospital in Germany, a Veteran's Affairs hospital, and 4 large urban tertiary care hospitals. Enrollment for the earliest study began in June 2008 and concluded for the most recent study on June 10, 2014. All participants were exposed to interventions (1 or 2 fluoroscopically guided epidural injections), while patients in one trial 12 were exposed to medications (gabapentin or placebo). A total of 361 patients were randomized in 3 studies. [10] [11] [12] Among 9 patients excluded from this analysis, 5 received nonstudy treatments and 4 were lost to follow-up at 1 month.
Main Outcome Measures
In all 3 studies, outcome data were obtained by research clinicians masked to the treatment group. Patients rated region-specific NRS scores to obtain separate values for back pain and leg pain. NRS scores ranged from 0 (no pain) to 10 (worst pain). NRS scores were assessed at baseline and at 1 month, with each score representing the average pain experienced by the patient in the 1 week preceding assessment. At 1 month, patients rated clinical improvement using global perceived effect (GPE), defined as a patient's positive response to the statements "My pain has improved/worsened/stayed the same since my last visit" and "I am satisfied/not satisfied with the treatment I received and would/would not recommend it to others."
Statistical Analysis
For each participant, characteristics for regional NRS scores were calculated using both absolute change (1 month value minus baseline value) and relative change (absolute change divided by baseline value).
Relative change scores could not be calculated for baseline NRS pain values of 0 (ie, for patients reporting radicular pain but no back pain), and accordingly those scores were not used in the relative change analysis. To characterize the association between regional NRS scores and meaningful patient improvement, values for sensitivity, specificity, and percent correct classification were derived using receiver operating characteristics (ROC). ROC curves characterize the predictive ability of a measure or scale at a range of cutoff values, with greater area under the curve (AUC) corresponding to enhanced predictive ability. In each analysis, patient improvement served as the dependent variable and either absolute or relative regional NRS score change served as the independent variable. Analyses were repeated for both back and leg NRS scores. A direct comparison of NRS ratings tested the equality of AUC for regional pain scores (ie, change in back vs. leg NRS scores) to predict patient improvement. All analyses were performed using Stata/IC 12.1 (StataCorp LP, College Station, TX, U.S.A.). P values for all tests were set at P = 0.05.
RESULTS
Study and Patient Characteristics
The pooled study population for our analysis consisted of 352 patients who had complete data available, including NRS pain ratings (both baseline and 1 month back and leg pain) and clinical improvement (global perceived effect) ( Table 2) . For the 17 patients with baseline back pain scores of 0, relative change scores were not calculated.
Comparison of Back and Leg Pain Ratings
All 3 studies reported a reduction in both back and leg pain scores at 1 month (Table 3 ). The reduction in leg pain NRS scores exceeded reductions in back pain scores in all 3 studies, and this was evident in assessments for both absolute change (leg mean AE SD = À2.4 AE 2.8; back = À1.5 AE 2.4) and relative change (leg = À38.1%; back = À25.2%). Meaningful clinical improvement was reported by similar percentages of patients across all 3 studies and in 62.8% of all patients.
Reductions in leg pain better predicted clinical improvement as measured by global perceived effect than reductions in back pain, as evidenced by a greater AUC in ROC analyses (Tables 4 and 5 ). This relationship remained consistent for both absolute and relative reductions in pain. The improvements in leg pain that were best associated with clinical improvement were an absolute value of ≥ 1.75 points reduction in NRS pain score and a 23.5% relative reduction in pain score (Figure 2) . The back pain reductions that optimally classified clinical improvement were an absolute value of ≥ 0.5 points in NRS pain score reduction and a relative reduction of ≥ 14.3%.
In subgroup analysis of 227 patients by recorded diagnosis of either herniated nucleus pulposus (HNP) (83%; n = 189) or spinal stenosis (17%; n = 38), leg pain demonstrated greater predictive ability to identify clinical improvement for both absolute and relative reduction for HNP (P < 0.001 for both models), but no difference in clinical improvement prediction was present for spinal stenosis (P = 0.35 and P = 0.24, respectively).
DISCUSSION
In patients with lumbosacral radicular pain, we found that reductions in average pain scores over the past week For absolute reduction, n = 352. For relative reduction, n = 335. Area under the curve calculated using receiver operating characteristic analysis. Absolute reduction in numeric rating scale (NRS) score was defined as NRS 1 month-NRS baseline. Relative reduction in NRS was defined as absolute reduction in NRS/NRS baseline. Figure 1A ) and relative reduction in pain ( Figure 1B ) is * significant to P < 0.001 and P = 0.002, respectively. Absolute reduction in NRS was defined as NRS 1 month -NRS baseline. Relative reduction in NRS was defined as absolute reduction in NRS/NRS baseline.
for both leg and back pain predicted patient-reported clinical improvement, based on data pooled from 3 recent randomized controlled trials of epidural steroid injections. Reductions in leg pain scores more accurately predicted patient-reported clinical improvement than reductions in back pain. This association remained consistent regardless of whether absolute or relative changes in pain scores were analyzed. To our knowledge, this is the first time that regional pain ratings have been used in an attempt to predict clinical improvement. These findings highlight 2 key differences for LSR, but largely concur with previous work performed on determining what constitutes a minimal clinically important change for patients in chronic pain. 5 First, for LSR, a less conservative cutoff for absolute reduction in region-specific leg pain scores of À1.75 provides slightly higher degrees of sensitivity, specificity, and percent correct classification than the cutoff of À2 suggested from nonspecific pain score models developed using data from various chronic pain diagnoses. When using region-specific leg pain scores in a clinical context, a change in pain of À2 points provides similar predictive values. Second, a smaller relative reduction in leg pain can result in clinically meaningful patient-reported outcomes for LSR than what has previously been reported. The cutoff for relative reductions in regionspecific pain scores found in LSR (À23.5%) was lower than values derived from other studies using nonspecific pain scores in other chronic pain conditions (À30%). Whereas the measure of clinical improvement, positive global perceived effect, was assessed using a 7-item categorical scale in the studies by Farrar et al., this outcome was recorded as a dichotomous outcome (yes/ no) in the 3 studies included in this analysis. The ability for absolute change in nonspecific pain score models to predict clinical improvement from Farrar et al. 5 (termed "raw change") aligns well with the absolute leg pain rating model for clinical improvement in this analysis. Overall, comparisons of these ROC analyses revealed similar predictive abilities and statistical properties, including correct classification.
A probable explanation for differences in these findings regarding LSR vs. other chronic pain conditions involves heterogeneity in patient expectations. [13] [14] [15] Past studies have demonstrated that patients pursuing specific treatments may have differing expectations regarding their outcome, such as a chronic limb patients opting for surgical treatment who anticipated complete relief of pain after surgery. 13 Expectations regarding anticipated outcomes play an important role in the process of response to treatment and the recovery process. 14, 15 These same expectations also likely contribute to the well-known placebo effect, as observed by Beecher in his 1955 publication "The Powerful Placebo. with expectations of pain relief may have analgesia from placebo due to various biological mechanisms, including endogenous opioid, dopamine, and cholecystokinin receptors. 17 This may be particularly relevant for interventions such as ESI, as studies have shown that the placebo effect is more powerful for procedures than medications. 18 Regardless of the mechanism, the placebo response plays a prominent role in pain clinical trials, with increasing placebo responses over time in clinical trials of some pain conditions in the United States. 19 Epidural steroid injections are most frequently utilized for radicular pain stemming from either a herniated disk or spinal stenosis. Although the presentation of both etiologies may appear similar to nonmedical personnel, the 2 conditions differ by pathophysiology, and the latter may not respond as well to ESI. 20, 21 Radicular pain from a herniated disk typically results from mechanical or chemical nerve root irritation, whereas chronic arterial ischemia and/or venous congestion of the affected nerve roots play a prominent role in neurogenic claudication. 22 We found that reduction in leg pain scores predicted clinical improvement in patients with a herniated disk, while the prediction tool fell shy of statistical significance when spinal stenosis patients were analyzed separately. One possible explanation for this is that the 2 conditions affect quality of life differently, and the elderly, often retired patients who presented with spinal stenosis may have had different expectations than the younger, more active individuals with herniated disks. However, a second possibility is that the predictive value of leg pain is similar for the 2 cohorts, but the small number of people with spinal stenosis precluded the chance to achieve statistical significance.
Proper interpretation of these findings should take into account certain limitations of this analysis. These findings may lack generalizability to patient populations beyond adult patients with LSR who consider interventional treatments. A majority of the patients recruited in 2 of the 3 studies were male with a military affiliation, reflecting the participating study sites. These patients may be younger, face different physical and psychological stressors, and have a different mindset regarding pain and disability. On the other hand, outcome characteristics demonstrated similar trends across all 3 studies. Female participants comprised at least one-fourth of participants in each study and more than one-third of the participants in this analysis. Caution should be given to generalizing these findings to outcomes longer than 4 weeks in duration. It is also possible that baseline patient characteristics other than those measured across all 3 studies likely influenced overall clinical improvement. The concordance of findings from this analysis to past studies supports the idea that pain reduction for patients with LSR contributes to clinical improvement in a meaningful way.
In conclusion, an analysis of data from 3 randomized controlled studies supports the use of region-specific pain cutoff ratings to predict clinical improvement for patients with LSR. In particular, leg pain ratings provide superior prognostic ability in comparison with back pain ratings regarding patient-reported clinical improvement. Prior guidelines based on data from chronic pain populations that did not include LSR suggested pain reduction cutoffs of 2 points of 30%, which may be too conservative to accurately predict clinical improvement for lumbosacral radicular pain. The smaller cutoffs proposed in this analysis, using reductions of À1.75 points and 23.5%, appear to most accurately predict clinical improvement and should be strongly considered for use when designing clinical trials or interpreting the results of existing studies. Regardless of which cutoffs future studies employ in analysis of pain scores, these findings support the concept that patients with lumbosacral radicular pain may have different expectations given that meaningful clinical improvement occurs with smaller reductions in pain in comparison with other chronic pain diagnoses.
